Back to top
more

Stryker (SYK)

(Delayed Data from NYSE)

$307.80 USD

307.80
3,427,831

+6.66 (2.21%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $307.00 -0.80 (-0.26%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (175 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Stryker (SYK) to Gain From Solid Portfolio and Acquisitions

by Zacks Equity Research

Stryker's (SYK) diverse portfolio and accretive acquisitions is instrumental in aiding the company's top-line growth.

    Zacks Equity Research

    3 Plastic & Reconstructive Surgery Stocks Looking Good

    by Zacks Equity Research

    Consider these three stocks for raking in grand returns from the fast-growing plastic and reconstructive surgery market.

      Zacks Equity Research

      Stryker (SYK) to Gain From Solid Portfolio and Acquisitions

      by Zacks Equity Research

      Stryker Corporation (SYK) has successfully expanded its product portfolio over time, which aids the company to cater to evolving demands of customers.

        Zacks Equity Research

        NuVasive Acquires Vetera Spine, Grows With Spinal Hardware

        by Zacks Equity Research

        NuVasive aims to market and distribute Vetera Spine's FDA-approved COHERE Cervical and COALESCETM Lumbar Interbody fusion devices in the United States.

          Zacks Equity Research

          Mazor Robotics' CE Mark for Mazor X Platform to Drive Orders

          by Zacks Equity Research

          Mazor Robotics and Medtronic will now be able to market and sell the Mazor X Surgical Assurance Platform in countries that recognize the CE Mark.

            Zacks Equity Research

            Model N (MODN) Rides on Revitas Buyout and Customer Wins

            by Zacks Equity Research

            Model N (MODN) is gaining from positive synergies from the Revitas acquisition and frequent client wins.

              Zacks Equity Research

              The Zacks Analyst Blog Highlights: Mondelez, Colgate-Palmolive, Stryker, Nike and Fifth Third Bancorp

              by Zacks Equity Research

              The Zacks Analyst Blog Highlights: Mondelez, Colgate-Palmolive, Stryker, Nike and Fifth Third Bancorp

                Mark Vickery headshot

                Top Research Reports for Mondelez, Colgate-Palmolive & Stryker

                by Mark Vickery

                Today's Research Daily features new research reports on 16 major stocks, including Mondelez (MDLZ), Colgate-Palmolive (CL) and Stryker (SYK).

                  Zacks Equity Research

                  NuVasive Announces Vertera Spine Buyout, Boosts Implants Suite

                  by Zacks Equity Research

                  NuVasive (NUVA) to add three-dimensional porous interbody technology across polyetheretherketone (PEEK) material as well through the Vertera Spine buyout.

                    Zacks Equity Research

                    Accuray (ARAY) Grapples With Falling Margin and Product Mix

                    by Zacks Equity Research

                    Accuray Inc.'s (ARAY) low product margins and unfavorable product mix will continue to be a drag on the company's performance.